Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. April 3, 2019. Scott Gottlieb.

Executive Summary

To keep up with advances in artificial intelligence and machine learning in the health-care sector, US FDA is working to develop a draft guidance that would help sponsors gain clarity on what the agency expects from them. See what agency head Scott Gottlieb said about AI here.

“I can envision a world where, one day, artificial intelligence can help detect and treat challenging health problems, for example, by recognizing the signs of disease well in advance of what we can do today. These tools can provide more time for intervention, identifying effective therapies and ultimately saving lives.” –Scott Gottlieb, commissioner, US FDA

Click here for a free trial of Medtech Insight

 
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT124880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel